MedTrace Logo

Efficacy and Safety Morus Alba L. Extract on Improvement of Blood Flow

NCT03807570 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-05-08

No results posted yet for this study

Summary

The effect of 12 weeks intake of Morus alba L. on blood circulation improvement and related indicators is assessed compared to placebo intake.

Conditions

  • Blood Flow

Interventions

DIETARY_SUPPLEMENT

Morus Alba L. Extract

Morus Alba L. Extract 30 ml/day for 12 weeks.

DIETARY_SUPPLEMENT

Placebo

Placebo 30 ml/day for 12 weeks.

Sponsors & Collaborators

  • Chonbuk National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-12
Primary Completion
2021-01-30
Completion
2021-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03807570 on ClinicalTrials.gov